These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6168532)

  • 1. [Individual chemotherapy in blastic leukemias (AML)].
    Ihle R; Stobbe H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):232-6. PubMed ID: 6168532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of acute myeloblastic leukemia. Thoughts after preliminary results].
    Weinfeld A; Ridell B; Westin J
    Nord Med; 1970 Dec; 84(49):1574. PubMed ID: 5275102
    [No Abstract]   [Full Text] [Related]  

  • 3. A cat with acute myeloblastic leukemia without maturation (M1) treated with combination chemotherapy.
    Mashita T; Shimoda T; Yoshioka H; Takahashi Y; Mitsuda M
    J Vet Med Sci; 2006 Jan; 68(1):97-101. PubMed ID: 16462128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute myelogenous leukemia in adults].
    Rinsho Ketsueki; 1972 Feb; 13(1):62-83. PubMed ID: 4533030
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia].
    Tura S; Ricci P; Baccarani M; Lauria F; Santucci MA
    Haematologica; 1972; 57(7):359-70. PubMed ID: 4628583
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia].
    Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J
    Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative evaluation of various methods of treating acute leukemia].
    Khvatova NV; Lorie IuI; Solov'eva EA; Frenkel' MA
    Ter Arkh; 1971 May; 43(5):3-7. PubMed ID: 5286868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of acute leukemias].
    Gross R; Gerecke D
    Wien Klin Wochenschr; 1982 Nov; 94(21):591-6. PubMed ID: 6963072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.
    Horikoshi A; Takei K; Iriyama N; Uenogawa K; Ishizuka H; Shiraiwa H; Hosokawa Y; Sawada S; Kitoh T
    Acta Haematol; 2009; 122(1):54-7. PubMed ID: 19816010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences in the induction of remission and in maintenance therapy in acute myeloblastic leukemia in adults with the RAMPO scheme].
    Höche D; Herold M; Fink R; Anger G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):237-43. PubMed ID: 6168533
    [No Abstract]   [Full Text] [Related]  

  • 12. Biphenotypic acute leukaemia: a case series.
    Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
    Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of acute myeloid leukemia].
    Obrecht JP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):190-200. PubMed ID: 6208102
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for acute leukemia during pregnancy. Five case reports.
    Fassas A; Kartalis G; Klearchou N; Tsatalas K; Sinacos Z; Mantalenakis S
    Nouv Rev Fr Hematol (1978); 1984; 26(1):19-24. PubMed ID: 6584858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a new relapse treatment for acute myeloid leukemia (AML) on in vitro granulopoiesis.
    Müller MR; Sauter C; Erni J; Martz G
    Anticancer Res; 1983; 3(2):127-31. PubMed ID: 6573868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of acute leukosis with cytarabine].
    Almici C; Inzoli MR
    Haematologica; 1973; 58(3):172-4. PubMed ID: 4198239
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of in vitro lymphocyte transformation during chemotherapy in man.
    Hersh EM; Oppenheim JJ
    Cancer Res; 1967 Jan; 27(1):98-105. PubMed ID: 6020370
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract]   [Full Text] [Related]  

  • 20. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.